During the past decade, Watanabe Pediatric Allergy Clinic conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Watanabe Pediatric Allergy Clinic" are "Healthy Subjects" (2 trials) and "Tick-Borne Encephalitis" (1 trials). Many other conditions were trialed in "Watanabe Pediatric Allergy Clinic" in a lesser frequency.

Most popular intervention types in "Watanabe Pediatric Allergy Clinic" are "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "DTaP" (2 trials), "diphtheria, tetanus, and acellular pertussis vaccine (DTaP)" (2 trials), "13-valent pneumococcal conjugate vaccine (13vPnC)" (1 trials), "7-pneumococcal conjugate vaccine (7vPnC)" (1 trials) and "7-valent pneumococcal conjugate vaccine (7vPnC)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Watanabe Pediatric Allergy Clinic" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Watanabe Pediatric Allergy Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Watanabe Pediatric Allergy Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Watanabe Pediatric Allergy Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".